News

Three in 10 of your diabetic patients may have liver fibrosis
LOS ANGELES – For every 10 of your adult patients with type 2 diabetes, three are likely to have moderate to severe liver fibrosis, according to...
LOS ANGELES – For every 10 of your adult patients with type 2 diabetes, three are likely to have moderate to severe liver fibrosis, according to...
“This is an emerging disease that you’re all going to see in your practices this year," one expert says. For more news, check out today's briefing...
Female surgeons underrepresented in academic leadership roles, multivariable analysis shows.
New FDA site aims to get valuable updates on antibiotics out to health care professionals quicker to aid in prescribing decisions.
Shereef Elnahal, MD discusses VA’s new efforts to improve transparency, measure quality, and shares Diffusion of Excellence success...
Researchers have observed a low inhibitor rate in previously untreated patients (PUPs) with severe hemophilia A who received treatment with...
The US Food and Drug Administration (FDA) has approved a ready-to-use formulation of bivalirudin for use as an anticoagulant in patients...
The European Commission (EC) has granted orphan designation to gilteritinib for the treatment of patients with acute myeloid leukemia (AML)....
The Mayo Clinic analysis examines 16 patients with rheumatologic diseases and cancer who received checkpoint inhibitor therapy.
Overuse of antibiotics increases healthcare costs and contributes to the emergence of resistance, but these agents continue to be prescribed...